XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
ASSETS    
Investments at fair value $ 10,439,173 $ 9,868,440
Cash and cash equivalents 147,656 154,857
Deferred financing costs 14,753 16,450
Receivable for investments sold 14 1,295
Total assets 10,705,055 10,134,618
LIABILITIES    
Debt (net of unamortized debt issuance costs of $23,913 and $25,953 at March 31, 2024 and December 31, 2023, respectively) 5,274,114 4,911,930
Payable for investments purchased 19,322 8,566
Management fees payable (Note 3) 26,040 23,034
Income based incentive fees payable (Note 3) 35,845 34,373
Capital gains incentive fees payable (Note 3) 3,134 0
Interest payable 30,104 39,880
Distribution payable 147,743 143,052
Accrued expenses and other liabilities 4,332 12,817
Total liabilities 5,549,390 5,182,577
Commitments and contingencies (Note 7)
NET ASSETS    
Common Shares, $0.001 par value (unlimited shares authorized; 191,874,419 and 185,782,408 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively) 192 186
Additional paid in capital 4,869,433 4,701,827
Distributable earnings (loss) 286,040 250,028
Total net assets 5,155,665 4,952,041
Total liabilities and net assets $ 10,705,055 $ 10,134,618
Net asset (in usd per share) $ 26.87 $ 26.66
Affiliated Entity    
LIABILITIES    
Due to affiliates $ 8,756 $ 8,925
Non-controlled/non-affiliated investments    
ASSETS    
Investments at fair value 10,433,071 [1] 9,862,650 [2]
Interest receivable from non-controlled/non-affiliated investments 103,459 93,576
Non-controlled/affiliated investments    
ASSETS    
Investments at fair value $ 6,102 [1] $ 5,790 [2]
[1] Unless otherwise indicated, all debt and equity investments held by the Company (which such term “Company” shall include the Company’s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of March 31, 2024, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), Norwegian Krone (NOK), and Australian Dollars (AUD). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company’s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.
[2] Unless otherwise indicated, all debt and equity investments held by the Company (which such term “Company” shall include the Company’s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December 31, 2023, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company’s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.